Toggle Main Menu Toggle Search

Open Access padlockePrints

PKD1 5’UTR variants are a rare cause of disease in ADPKD and suggest a new focus for therapeutic development

Lookup NU author(s): Professor John SayerORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© The Author(s) 2025.Autosomal Dominant Polycystic Kidney Disease (ADPKD), caused by pathogenic variants in PKD1 and PKD2, is the most common monogenic cause of kidney failure. Approximately 10% of ADPKD patients remain undiagnosed after coding-region focused genomic testing. Non-coding variants in regulatory regions are not an established cause of disease in ADPKD. We performed regulatory region analysis in a primary cohort of undiagnosed ADPKD patients (n = 20) and then extended this analysis to patients with undiagnosed cystic kidney disease within the Australian KidGen cohort (n = 42) and the Genomics England rare disease cohort (n = 1320). Through this genomic analysis we identified two rare, potentially disease-causing variants in the PKD1 5′untranslated region (UTR). We then designed a PKD1 5′UTR-luciferase translation assay to characterise these variants in vitro, which showed that a PKD1 variant c.−69dupG, reduced the translation efficiency of the main PKD1 open reading frame by ~87% compared to wildtype (p < 0.0001). The human PKD1 5′UTR contains two upstream open reading frames (uORFs). Using our model, we knocked-out the upstream open reading frames of the wildtype PKD1 5′UTR sequence, which increased expression of wildtype polycystin-1 (130%, p < 0.0001). We show that PKD1 5′-UTR variants are a currently overlooked rare cause of disease in ADPKD and that analysis of this region should be included in variant analysis pathways to increase diagnostic rates. In addition, we show that manipulation of the wildtype 5′UTR sequence can increase polycystin-1 expression, providing insights into regulation of PKD1 and suggested new approaches for therapeutic intervention in this haplo-insufficient disease.


Publication metadata

Author(s): Wedd L, Hort Y, Patel C, Sayer JA, Rius R, Mallett AJ, Cottle DL, Smyth IM, Furlong T, Shine J, Mallawaarachchi A

Publication type: Article

Publication status: Published

Journal: European Journal of Human Genetics

Year: 2025

Pages: epub ahead of print

Online publication date: 26/09/2025

Acceptance date: 11/09/2025

Date deposited: 13/10/2025

ISSN (print): 1018-4813

ISSN (electronic): 1476-5438

Publisher: Springer Nature

URL: https://doi.org/10.1038/s41431-025-01949-z

DOI: 10.1038/s41431-025-01949-z

Data Access Statement: The individual genomic datasets from the Garvan and KidGen cohorts generated and analysed during the current study are available from the corresponding author on reasonable request. Permission can be sought to access data from the Genomics England cohort through the Genomics England Research Environment. The public datasets analysed during the current study are available in the gnomAD repository, https://gnomad.broadinstitute.org. The variants identified in this study have been submitted to Clinvar (SUB15496204)


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Kidney Research UK (Paed_RP_001_20180925, RP_007_20210729)
MRC (MR/Y007808/1)
Northern Counties Kidney Research Fund (20/01)
RACP Jacquot Foundation
The Lewis Foundation
The Sylvia and Charles Viertel Charitable Foundation

Share